Hainan Poly Pharm

Hainan Poly Pharm is a company listed under the stock ticker 300630 (CN).

View the org chart displaying its 9 main executives

Most searched biographies at Hainan Poly Pharm

• Minhua Fan, Chairman of the Board and General Manager
• Yadong Chen, Director
• Lei Pan, Independent Director

Create your alert
to follow the executive moves at Hainan Poly Pharm.

Hainan Poly Pharm has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Hainan Poly Pharm

Social media about Hainan Poly Pharm

• Hainan Poly Pharm on Wikipedia, Google News & Yahoo Finance
• Hainan Poly Pharm on LinkedIn, Twitter & YouTube

Call Hainan Poly Pharm at +86 898 ...

View the org chart

Register to receive your alert

Report an error